Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|November 15, 2021
Sustainable medicines use in clinical practice: A clinical pharmacological view on eco-pharmaco-stewardshipElizabeth Adeyeye, Benjamin Jaa Ming New, Fangyue Chen, et al.
Heart Failure Reviews|February 7, 2022
An updated systematic review on heart failure treatments for patients with renal impairment: the tide is not turningCong Ying Hey, Sérgio Barra, Rudolf Duehmke, et al.
Clinical Science (London, England : 1979)|June 5, 2024
Targeting the endothelium by combining endothelin-1 antagonism and SGLT-2 inhibition: better together?Phil Ambery, Peter J Greasley, Robert I Menzies, et al.
BMJ Open|December 22, 2022
Metabolic adverse events associated with systemic corticosteroid therapy-a systematic review and meta-analysisSpoorthy Kulkarni, Hannah Durham, Luke Glover, et al.
Journal of Human Hypertension|November 14, 2023
Diagnosis and management of primary hyperaldosteronism in patients with hypertension: a practical approach endorsed by the British and Irish Hypertension SocietyLuca Faconti, Spoorthy Kulkarni, Christian Delles, et al.
British Journal of Pharmacology|March 29, 2022
Niclosamide-A promising treatment for COVID-19Shivani Singh, Anne Weiss, James Goodman, et al.
Journal of Human Hypertension|November 23, 2022
Management of hypertensive crisis: British and Irish Hypertension Society Position documentSpoorthy Kulkarni, Mark Glover, Vikas Kapil, et al.
Journal of Hypertension|March 14, 2025
Blood pressure variability: a reviewSpoorthy Kulkarni, Gianfranco Parati, Sripal Bangalore, et al.
Journal of Human Hypertension|December 9, 2024
Investigation and management of resistant hypertension: British and Irish Hypertension Society position statementLuca Faconti, Jacob George, Sarah Partridge, et al.
Trials|July 10, 2020
Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trialSpoorthy Kulkarni, Marie Fisk, Michalis Kostapanos, et al.
Pageof 3